Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16162141Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$6.8M
Full award amounts, FY2025
Award Records
9
Records listing this PI
Award-Linked Rank
#875
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $6.8M in linked award amounts across 9 award records · Award-linked rank #875.
FY2025 award records by amount
NIH award records listing Arun Rajan as a PI. Multi-PI records show the full award amount for context.
- $4.2Maward amount
- $749.2Kaward amount
- 1ZIABC011900-07ZIAPilot Study of Avelumab in Thymic Epithelial Tumors$530.2Kaward amount
- 1ZIABC012106-04ZIAA Phase II Trial of PT-112 in Subjects with Thymoma and Thymic Carcinoma$477.2Kaward amount
- 1ZIABC012001-06ZIAPhase II Trial of Bintrafusp Alfa in Subjects with Thymoma and Thymic Carcinoma$353.5Kaward amount
- 1ZIABC011907-07ZIADurvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer$176.7Kaward amount
- 1ZIABC011905-07ZIAAnti-PD-L1-TGFb antibody (M7824) in advanced Non-Small Cell Lung Cancer$176.7Kaward amount
- $35.3Kaward amount
- 1ZIABC011906-07ZIACV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer$17.7Kaward amount
Award organization
Organizations that administered FY2025 awards listing Arun Rajan as a PI.
FY2025 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardDivision of Basic Sciences - Nci
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #875
- 2025Entered Top 25% NationallyRanked #875
- 2025Entered Top 10% NationallyRanked #875
- 2025Entered Top 5% NationallyRanked #875